Webinar: How to monitor impurities and ensure consistent gene therapies

21 September 2021

It can be challenging to find a suitable commercial ELISA to monitor the process-related impurities in cell and gene therapies.

E.g., due to the use of a novel cell line because there are impurities from multiple organisms.

On October 5, Ejvind Mortz shows how Mass spectrometry (LC-MS) provides unrivaled HCP quantification and high reproducibility of each protein impurity – down to low ppm levels.

Learn more →